SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-004562
Filing Date
2015-05-21
Accepted
2015-05-21 16:31:40
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cdtx-10q_20150331.htm 10-Q 909178
2 EX-31.1 cdtx-ex311_201503318.htm EX-31.1 14645
3 EX-31.2 cdtx-ex312_201503319.htm EX-31.2 14774
4 EX-32.1 cdtx-ex321_2015033110.htm EX-32.1 11749
5 EX-32.2 cdtx-ex322_2015033111.htm EX-32.2 11646
  Complete submission text file 0001564590-15-004562.txt   4486167

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20150331.xml EX-101.INS 552945
7 XBRL TAXONOMY EXTENSION SCHEMA cdtx-20150331.xsd EX-101.SCH 31187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdtx-20150331_cal.xml EX-101.CAL 23665
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdtx-20150331_def.xml EX-101.DEF 113575
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdtx-20150331_lab.xml EX-101.LAB 273209
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdtx-20150331_pre.xml EX-101.PRE 206270
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 15883173
SIC: 2836 Biological Products, (No Diagnostic Substances)